Molecule Runtime
Understand how your molecule is living across humans.
1,800 synthetic trajectories · 244,774 observations · continuously learning
GI toxicity in solid-tumour therapy
How NBL-101 lives across 600 people: response, tolerance, and the GI patterns that decide whether they stay on therapy.
GLP-1 receptor agonist
Weight and metabolic response over 180 days, with early nausea as the main reason people stop.
Immune-mediated response
Immune response, inflammatory load and fatigue across 500 trajectories, including an unexpected resilient responder group.
Biological state → intervention → response → learning. Every recommendation closes a loop that LIFE OS learns from.
Not a dashboard about a drug. An interface for interacting with a drug as it lives across thousands of human trajectories.
Everything here is synthetic. Fictional molecules, generated people, simulated outcomes. No medical recommendations.